pH: 6.0-6.5 clinical trials

A phase-2, multi-centre, prospective, randomized, standard-of-care plus placebo-controlled, patient and central evaluator blinded, parallel arm, clinical study to evaluate safety, tolerability and efficacy of the recommended phase-2 dose of AUP1602-C in two dosing frequencies as a topical treatment for non-healing neuro-ischemic diabetic foot ulcers

This study looks at a new topical treatment, AUP1602-C, for tricky-to-heal foot ulcers in people with diabetes. We want to see if it's safe, helps wounds close, and how often it needs to be applied, compared to a dummy treatment.